Thalia Therapeutics, a prominent British BioTech company specializing in RNA-based therapeutics and delivery technologies for oncology and cardiovascular diseases, has recently made headlines with the acquisition...
SignaCor Therapeutics, a HealthTech startup based in Belfast, has secured €288k (£250k) in funding from VC firm Zinc to further develop a new treatment aimed at...
Oxford BioTech startup Scripta Therapeutics has officially emerged from stealth mode with the announcement of a €10.3 million ($12 million) Seed round to revolutionize traditional approaches...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.